🔎 Trials Near Me

Domov › Sladkorna bolezen tipa 2 › Texas › Houston

Klinične študije za Sladkorna bolezen tipa 2 v Houston, TX

31 študij za Sladkorna bolezen tipa 2 išče udeležence na lokacijah v Houston in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)

Vključevanje udeležencev
  • Houston Methodist, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06906640

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Vključevanje udeležencevFaza 2
  • Cardiovascular Specialists of Willowbrook, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07783802

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

Vključevanje udeležencevFaza 3
  • JCCT- Juno NW Houston, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07817251

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Vključevanje udeležencevFaza 3
  • Victorium Clinical Research, Houston
  • Houston Research Institute, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07064473

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

Vključevanje udeležencevFaza 3
  • Juno Research, LLC, Houston
  • Biopharma Informatic, Inc. Research Center, Houston
  • Research Physicians Network, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07754461

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

Vključevanje udeležencevVabljeni zdravi prostovoljci
  • Helium Research Group, Houston
  • Kelsey Research Foundation, Houston
  • The Methodist Hospital, DeBakey Cardiology Associates, Houston
  • in še 1
Starost 55 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT06112418

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Vključevanje udeležencevFaza 3
  • PlanIt Research, LLC (Monitoring Room), Houston
  • PlanIt Research, LLC, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07595549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • Juno Research, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Vključevanje udeležencevFaza 3
  • Research Site, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07784270

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • AURORA-2 Clinical Site, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • HRI ? Medical Center, LLC, Houston
  • Juno Research, LLC, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Vključevanje udeležencevFaza 2
  • Juno Research, Houston
Starost 18–75 · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT06897475

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

Vključevanje udeležencevFaza 2
  • JCCT- Juno NW Houston, Houston
Starost 18–75 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07415954

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

Vključevanje udeležencevFaza 2
  • Juno Research, LLC, Houston
  • Prolato Research LLC, Houston
  • Clinical Trial Network, LLC, Houston
Starost 18–80 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07271186

A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes

Vključevanje udeležencevFaza 2
  • Private Practice - Dr. Laila A. Hassan, Houston
Starost 18–75 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07668388

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

Vključevanje udeležencevFaza 3
  • Research Site, Houston
  • Research Site, Houston
  • Research Site, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07662213

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Vključevanje udeležencevFaza 2
  • Juno Research, LLC, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07296484

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • Amir Ali Hassan, MD, PA, Houston
Starost 10–18 · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07282613

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Vključevanje udeležencevFaza 2
  • Biopharma Informatic, LLC, Houston
  • PlanIt Research, PLLC, Houston
  • Research Physicians Network, LLC, Houston
Starost 18–75 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT07215559

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Vključevanje udeležencevFaza 3
  • JCCT- Juno Northwest Houston, Houston
  • Johnson County Clinical Trials Juno Bellaire, Bellaire · 7 mi stran
Starost 18–99 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07684144

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

Vključevanje udeležencevFaza 3
  • PrimeCare Medical Group, Houston
  • JCCT- Juno NW Houston, Houston
  • Biopharma Informatic_Houston, Houston
  • in še 2
Starost 45 in več · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT07797335

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

Vključevanje udeležencevFaza 3
  • Texas Childrens Hospital, Houston
  • UT Health Houston, Houston
Starost 10–17 · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT06739122

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin

Vključevanje udeležencevFaza 3
  • Research Site, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 4. avg. 2026 · NCT07664553

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

Vključevanje udeležencev
  • Baylor College of Medicine, Houston
Starost 14–75 · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT07579702

Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents

Vključevanje udeležencevVabljeni zdravi prostovoljciOmenja plačilo za udeležence
  • USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine, Houston
Starost 14–16 · Vsi spoli · Posodobljeno 7. jul. 2026 · NCT06943001

CGM for Management of Type 2 Diabetes in Pregnancy

Vključevanje udeležencev
  • University of Texas Health Science Center at Houston, Houston
Starost 18–50 · Ženske · Posodobljeno 29. jun. 2026 · NCT06628453

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

Vključevanje udeležencevFaza 2
  • Synergy Group Medical, Houston
Starost 18–70 · Vsi spoli · Posodobljeno 15. jun. 2026 · NCT07502508

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

Vključevanje udeležencevOpazovalna študija
  • Baylor College of Medicine / Texas Children's, Houston
Starost 8–15 · Vsi spoli · Posodobljeno 7. maj 2026 · NCT06525259

Determinants of Insulin Sensitivity by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
  • Lilli Health, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 1. maj 2026 · NCT05950282

RESET System Pivotal Trial (Rev F)

Vključevanje udeležencev
  • Baylor College of Medicine, Houston
Starost 22–65 · Vsi spoli · Posodobljeno 18. jul. 2024 · NCT04101669

Študije za Sladkorna bolezen tipa 2 v drugih mestih

Druge študije v Houston

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.